VITALE ROBERT V

Director Vitale buys 21,009 shares of ENR at $23.55; holdings surge 913.4% to 23,309 shares amid 6-insider cluster buy.

Robert V. Vitale, a director, purchased 21,009 shares at $23.55 on 2025-05-21, lifting his total holdings from 2,300 to 23,309 shares (+913.4%). This transaction occurs within a larger cluster pattern in which 6 other insiders also bought within the past 14 days. The stock has declined 42.1% from its 52-week high of $39.39 and has fallen 16.2% over the past 30 days and 26.1% over 90 days. Fundamental metrics show revenue of $662,900,000.00 with net income of $28,300,000.00, though annual revenue growth stands at -2.5% and the P/E ratio is elevated at 30.43. The coordinated buying activity by multiple insiders against a backdrop of sharp price decline and negative growth raises questions about whether this reflects informed conviction or other factors driving synchronized acquisition behavior.

Post Holdings CEO Vitale sold 63,243 shares for $7,326,067.50 across 4 transactions Feb 24-25

Robert V. Vitale, President & CEO of Post Holdings, executed 4 separate sales totaling 63,243 shares for $7,326,067.50 at a blended average price of $115.84 over Feb 24-25, reducing his holdings from 900,442 shares to 837,199 shares (a 7.0% reduction). The sales occurred near the stock's 52-week high of $120.72, with the current price at $113.19, suggesting the transactions were executed at favorable valuations relative to recent price action. Vitale has a documented history of 18 prior open-market sells across his trading record, indicating a pattern of opportunistic liquidations rather than a first-time or exceptional event. Against fundamentals showing revenue of $1,974,700,000.00 and net income of $113,300,000.00 with 13.3% annual revenue growth, the scale of this sale warrants monitoring as context for understanding management's view of forward cash needs or valuation positioning.

Director Robert V Vitale sells 29,723 shares at $72.65 avg for $2.16M; stock down 9.7% in 30 days

Director Robert V Vitale executed 3 separate sales totaling 29,723 shares for $2,159,361.99 on 2025-02-24 and 2025-02-25 at an average price of $72.65. The sales reduce his holdings by 3.6%, from 833,180 shares to 803,457 shares. The timing of these transactions is notable: they occurred within days of a heavy cluster of sales on 2025-02-20 and 2025-02-21 (5 prior trades at BRBR), and BELLRING BRANDS stock is currently down 9.7% over the past 30 days and 9.9% below its 52-week high of $79.39. With the stock trading at $71.50 versus his blended sale price of $72.65, the director sold marginally above the current level. The rapid succession of sales (5 trades in 4 days) suggests active position reduction near recent support levels, with fundamentals showing strong growth (revenue +19.8% YoY) and profitability ($76.9M net income on $532.9M quarterly revenue).

Director Robert V. Vitale sold 15,000 shares of BRBR at blended average $73.47; currently holds 833.2K shares post-transaction.

On 2025-02-21, director Robert V. Vitale executed 3 separate sales totaling 15,000 shares for $1,102,000.88 at prices ranging from $73.05 to $74.84. Post-transaction holdings of 833.2K shares represent a 1.8% reduction from his 848.2K-share position. The sale occurred as BRBR traded near its 52-week high of $79.39, with the stock currently down 8.2% from that peak and 4.1% over 30 days, though the company maintains strong fundamentals with $532.9M quarterly revenue, $76.9M net income, and 19.8% annual revenue growth. The filing provides observable facts about transaction timing and price levels but does not establish a pattern of prescient market timing by the insider—this transaction and five recent prior sales at BRBR do not yet have measurable 90-day outcomes.

Director Robert V Vitale sells 46,766 shares at $74.72 blended average for $3,494,520.31 at BRBR

Robert V Vitale, a Director at BellRing Brands, executed 3 separate sales on 2025-02-20 totaling 46,766 shares for $3,494,520.31, reducing his holdings from 894,946 to 848,180 shares (a -5.2% reduction). The sales were executed at prices ranging from $74.33 to $76.24, with a blended average of $74.72, occurring at a time when the stock trades at $72.97 (a -2.3% discount to the blended sale price). The company reports strong fundamentals with annual revenue growth of +19.8%, a net income of $76,900,000.00, and a market cap of $9,360,820,652.83. The stock is currently -8.1% from its 52-week high of $79.39 and has declined -4.3% over 30 days and -7.2% over 90 days, suggesting recent price weakness. His prior trades at BRBR have not yet generated measurable 90-day outcomes, limiting the ability to assess his historical timing accuracy at this specific ticker.

Director VITALE ROBERT V sells 43,511 shares of BRBR at $77.35 ($3.4M), reducing stake by 4.6%; stock now -6.6% from 52-week high.

VITALE sold 43,511 shares at $77.35 on 2025-02-19, representing a 4.6% reduction in his 938.5K share position. The sale occurred near the 52-week high ($79.39), with the stock currently trading at $74.16, down 6.6% from that peak. VITALE's cross-ticker track record shows 11 prior open-market sales, though timing outcomes for those sales are not yet measurable. At BRBR specifically, VITALE has executed five prior sales (including additional sales on 2025-02-18 and 2025-02-20), with no measurable 90-day outcomes available to assess pattern accuracy. The company carries a P/E of 34.02 and is growing revenue at 19.8% annually with strong fundamentals ($532.9M quarterly revenue, $76.9M net income), making this a sell by a director of a high-growth, profitably-trading business rather than a distressed seller.

Director Robert V. Vitale sold 44,249 shares in 2 transactions for $3,423,486.01 on 2025-02-18

Director Robert V. Vitale executed 2 separate sales totaling 44,249 shares for $3,423,486.01 at a blended average price of $77.37, reducing his position from 982,706 to 938,457 shares (-4.5%). The sales occurred near the stock's 52-week high of $79.39 (current price $77.38 is -2.5% from that peak), and the transaction prices of $77.30 and $77.63 represent execution near elevated valuations. However, the timing context is limited: the stock has gained 6.9% over the past 30 days and 1.2% over 90 days, and Vitale's prior trades at BRBR are all recent (within the past week as of the filing date) with outcomes not yet measurable. His cross-ticker sell track record shows 7 prior sales, but no historical timing data is available to establish a pattern of accuracy.

Director Robert V. Vitale sold 79,068 shares at blended average $77.04 for $6.1M; still holds 982.7K shares.

On 2025-02-14, Director Robert V. Vitale executed two separate sales totaling 79,068 shares for $6,091,113.36 at a blended average price of $77.04, reducing his holdings from 1,061,774 shares to 982.7K shares (a 7.4% reduction). The sales occurred near the 52-week high of $79.39, with current price at $77.40. Vitale maintains substantial holdings of 982.7K shares post-transaction, indicating continued material ownership. His cross-ticker track record shows 6 prior open-market sells, while at BRBR specifically he has completed 5 prior sales within the past week (2025-02-11 through 2025-02-18), suggesting a pattern of recent liquidity events at this ticker. With BRBR trading at a P/E of 35.50 and recent annual revenue growth of 19.8%, the context is a company with strong fundamentals, though the timing and frequency of recent sales warrants attention to any underlying business developments or strategic shifts.

Director VITALE ROBERT V sold 48,230 shares of BRBR at $77.52 on 2025-02-13; retains 1,061,774 shares post-transaction.

Director Robert V. Vitale sold 48,230 shares at $77.52, reducing his position from 1,110,004 to 1,061,774 shares (a -4.3% reduction). This sale occurred near the 52-week high of $79.39, just 3.4% below the peak. The company shows solid fundamentals with $532.9M in latest-quarter revenue, 19.8% annual revenue growth, and $76.9M in net income, though the P/E of 35.17 reflects a premium valuation. The transaction is moderate in context: Vitale maintains over 1M shares post-sale, indicating continued meaningful ownership, and recent trading history at BRBR shows five other sales within the prior four days (2025-02-11 through 2025-02-14), suggesting an execution pattern rather than a single discretionary decision.

Director Robert Vitale sold 28,453 shares of BRBR at $76.91 on 2025-02-12 for $2,188,320.23.

Robert Vitale, a director of Bellring Brands, sold 28,453 shares at $76.91 on 2025-02-12, reducing his holdings from 1,138,457 to 1,110,004 shares (-2.5%). The sale occurred near the 52-week high of $79.39 and within recent upward momentum (30-day change +6.7%, 90-day change +7.6%), suggesting execution during a period of relative strength. However, Vitale maintains a substantial position of 1,110,004 shares post-transaction, indicating no material reduction in his equity stake. His cross-ticker track record shows 3 prior open-market sells, but outcomes at the 90-day mark are not yet measurable for comparison. At BRBR specifically, he has executed three prior trades in early February 2025, though timing assessment cannot be applied due to insufficient post-transaction observation windows.